Trademark Overview
On Tuesday, October 14, 2025, a trademark application was filed for SPIKIMM with the United States Patent and Trademark Office. The USPTO has given the SPIKIMM trademark a serial number of 79442271. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, July 14, 2026. This trademark is owned by SPIKIMM. The SPIKIMM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Scientific research for medical purposes; biological research; biochemical research; research and development services for pharmaceutical preparations; medical and scientific research, namely, conducting clinical trials for others; clinical research in the field of pharmaceuticals for the prevention of viral infections; conducting scientific studies and analyses in the field of monoclonal antibodies for the prevention of viral infections; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.
Pharmaceutical products, namely, monoclonal antibodies for the prevention of viral infections in immunocompromised patients; monoclonal antibodies for medical use; monoclonal antibodies for pharmaceutical and therapeutic use, namely, for the prevention of viral infections; chemical and biological preparations, for therapeutic, medical, pharmaceutical use, namely, monoclonal antibody preparations for the prevention of viral infections; diagnostic preparations for therapeutic use, namely, for diagnosing viral infections and diagnostic preparations for medical use; chemical reagents for medical use; reagents for development of monoclonal antibodies for medical use.
